385 related articles for article (PubMed ID: 30672818)
21. Extracorporeal renal and liver support in pediatric acute liver failure.
Zoica BS; Deep A
Pediatr Nephrol; 2021 May; 36(5):1119-1128. PubMed ID: 32500250
[TBL] [Abstract][Full Text] [Related]
22. Artificial liver support devices as treatment option for liver failure.
Nevens F; Laleman W
Best Pract Res Clin Gastroenterol; 2012 Feb; 26(1):17-26. PubMed ID: 22482522
[TBL] [Abstract][Full Text] [Related]
23. Current Evidence for Extracorporeal Liver Support Systems in Acute Liver Failure and Acute-on-Chronic Liver Failure.
Karvellas CJ; Subramanian RM
Crit Care Clin; 2016 Jul; 32(3):439-51. PubMed ID: 27339682
[TBL] [Abstract][Full Text] [Related]
24. The molecular adsorbent recirculating system as a liver support system: summary of Mexican experience.
Cisneros-Garza LE; Muñoz-Ramírez Mdel R; Muñoz-Espinoza LE; Ruiz Velasco JA; Moreno-Alcántar R; Marín-López E; Méndez-Sánchez N
Ann Hepatol; 2014; 13(2):240-7. PubMed ID: 24552866
[TBL] [Abstract][Full Text] [Related]
25. [MARS (Molecular Adsorbent Recycling System) as a novel hepatic detoxification procedure until orthotopic liver transplantation].
Ullerich H; Avenhaus W; Menzel J; Dietl KH; Domschke W; Lerch MM
Z Gastroenterol; 2001 Dec; 39(12):1023-6. PubMed ID: 11753787
[TBL] [Abstract][Full Text] [Related]
26. [Liver support systems today].
Rikker C
Orv Hetil; 2009 Dec; 150(51):2299-307. PubMed ID: 19995693
[TBL] [Abstract][Full Text] [Related]
27. MCP-1 and MIP3-alpha serum levels in acute liver failure and molecular adsorbent recirculating system (MARS) treatment: a pilot study.
Roth GA; Faybik P; Hetz H; Ankersmit HJ; Hoetzenecker K; Bacher A; Thalhammer T; Krenn CG
Scand J Gastroenterol; 2009; 44(6):745-51. PubMed ID: 19247846
[TBL] [Abstract][Full Text] [Related]
28. A single center retrospective study: Comparison between centrifugal separation plasma exchange with ACD-A and membrane separation plasma exchange with heparin on acute liver failure and acute on chronic liver failure.
Zhu XF; Li JQ; Liu TT; Wang Y; Zhong Y; Gao QM; Zhang Q; Yu KK; Huang C; Li N; Lu Q; Zhang WH; Zhang JM; Xia R; Zheng JM
J Clin Apher; 2024 Feb; 39(1):e22103. PubMed ID: 38098278
[TBL] [Abstract][Full Text] [Related]
29. Plasma exchange for acute and acute-on-chronic liver failure: A systematic review and meta-analysis.
Beran A; Mohamed MFH; Shaear M; Nayfeh T; Mhanna M; Srour O; Nawras M; Mentrose JA; Assaly R; Kubal CA; Ghabril MS; Hernaez R; Patidar KR
Liver Transpl; 2024 Feb; 30(2):127-141. PubMed ID: 37530812
[TBL] [Abstract][Full Text] [Related]
30. Extracorporal hemodialysis with acute or decompensated chronical hepatic failure.
Hessel F; Grabein K; Schnell-Inderst P; Siebert U; Caspary W; Wasem J
GMS Health Technol Assess; 2006 Apr; 2():Doc08. PubMed ID: 21289959
[TBL] [Abstract][Full Text] [Related]
31. Artificial liver support devices for fulminant liver failure.
Sechser A; Osorio J; Freise C; Osorio RW
Clin Liver Dis; 2001 May; 5(2):415-30. PubMed ID: 11385970
[TBL] [Abstract][Full Text] [Related]
32. The effect of molecular adsorbent recirculating system treatment on survival, native liver recovery, and need for liver transplantation in acute liver failure patients.
Kantola T; Koivusalo AM; Höckerstedt K; Isoniemi H
Transpl Int; 2008 Sep; 21(9):857-66. PubMed ID: 18510596
[TBL] [Abstract][Full Text] [Related]
33. Molecular adsorbent recirculating system as artificial support therapy for liver failure: a meta-analysis.
Vaid A; Chweich H; Balk EM; Jaber BL
ASAIO J; 2012; 58(1):51-9. PubMed ID: 22210651
[TBL] [Abstract][Full Text] [Related]
34. Role of therapeutic plasma exchange in acute liver failure due to yellow phosphorus poisoning.
Varghese J; Joshi V; Bollipalli MK; Malleeswaran S; Patcha R; Nair H; Vij V; Sachan D; Subramanian P; Jain M; Venkataraman J
Indian J Gastroenterol; 2020 Dec; 39(6):544-549. PubMed ID: 33409946
[TBL] [Abstract][Full Text] [Related]
35. Effect of molecular adsorbents recirculating system treatment in children with acute liver failure caused by Wilson disease.
Rustom N; Bost M; Cour-Andlauer F; Lachaux A; Brunet AS; Boillot O; Bordet F; Valla F; Richard N; Javouhey E
J Pediatr Gastroenterol Nutr; 2014 Feb; 58(2):160-4. PubMed ID: 24458219
[TBL] [Abstract][Full Text] [Related]
36. Bridging therapies and liver transplantation in acute liver failure, 10 years of MARS experience from Finland.
Kantola T; Ilmakunnas M; Koivusalo AM; Isoniemi H
Scand J Surg; 2011; 100(1):8-13. PubMed ID: 21482500
[TBL] [Abstract][Full Text] [Related]
37. Extracorporeal liver support devices for listed patients.
Lee KC; Stadlbauer V; Jalan R
Liver Transpl; 2016 Jun; 22(6):839-48. PubMed ID: 26785141
[TBL] [Abstract][Full Text] [Related]
38. Prognosis of acute-on-chronic liver failure patients treated with artificial liver support system.
Zhou PQ; Zheng SP; Yu M; He SS; Weng ZH
World J Gastroenterol; 2015 Aug; 21(32):9614-22. PubMed ID: 26327769
[TBL] [Abstract][Full Text] [Related]
39. Use of the molecular adsorbent recirculating system (MARS™) for the management of acute poisoning with or without liver failure.
Wittebole X; Hantson P
Clin Toxicol (Phila); 2011 Nov; 49(9):782-93. PubMed ID: 22077243
[TBL] [Abstract][Full Text] [Related]
40. Comparison of plasma exchange, double plasma molecular adsorption system, and their combination in treating acute-on-chronic liver failure.
Guo X; Wu F; Guo W; Zhang J; Yang Y; Lu Y; Yin C; Fan H; Xu J; Liao M
J Int Med Res; 2020 Jun; 48(6):300060520932053. PubMed ID: 32552092
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
